Looking more like Kellum has been around for over a decadeWasn't he also the "Lead memeber of the DSMB" in the Euphrates Trial?
While still serving as a 'special advisor' to CTSO and many other?
Geez, I wonder where the Cyto XL idea came from? ; - ) ..has it ever been used on a human?
Bear in mind, apparently it looks "amateurish" to divulge phase 3B Open Label trials where 60-80% shareholders might already be well aware of results...
BUT..not AT ALL amateurish to mislead investers by telling them publically that 62% of those NOT enrolled at "dying" ....slick doc ; - )
I have more, BUT I will wait for the "gang" to over burden this post..shameful but of Beech Boys ; - (
We are going to need disclosure on the 'Alter-cyte' arrangement ( circa 2012 ) The company was questioned about this "arrangement" and shareholders were not provided any answers. We were told "it might be important down the road, and for now it was not important"
We also want to know WHO received the 1.7M CAD "one-time charge" that "tanked the quarter" and kick-started the near 70M share dilution party on the back of too many advances to mention ( though there is a list )
It appears as though things aren't nearly "johnny come-lately" as we are led to believe. I've known this for over a decade.
Whether it is the company, the board or the our Stikeman rep, we need clarification on Alter-cyte;
DR PAUL WALKER COWORKERS AT ALTERCYTE INC. (5)
Dr John Kellum
Shareholder at Altercyte Inc. · Pittsburgh
Dr Kai Singbartl
Shareholder at Altercyte Inc. · Pittsburgh
David Valenti
Administrative Assistant at Altercyte Inc. · Pittsburgh
Dr William Federspiel
Shareholder at Altercyte Inc. · Pittsburgh
Anthony Businskas
Chief Financial Officer at Altercyte Inc. · Pittsburgh